Premium Reports
Robotic Process Automation 2021
New

Robotic Process Automation 2021
Adoption Moving Mainstream

January 31, 2021 | Read Time: 6  minutes

Current Time Inside Cache Tag Helper: 3/3/2021 1:45:22 AM and Model.reportId = 1642

Use of robotic process automation (RPA) technology in healthcare continues to grow. Early adopters focused primarily on automating repetitive and time-consuming revenue cycle management (RCM) tasks. Having achieved positive ROIs, they see the opportunity to drive additional efficiency and bottom-line improvements, both within RCM and in other areas of their organizations. This report dives into the performance of several early leaders in RPA to compare how they perform and how well they meet customers’ needs and expectations.

Note: While multiple vendors in this report offer automation as a service, only Olive does so exclusively. Readers can find customer experience information about Olive’s managed services offering in a separate section at the end of this report.

Healthcare Providers,
Want to see full details?

Not a Provider, contact us for pricing details.

Current Time Inside Cache Tag Helper: 3/3/2021 1:45:22 AM and Model.reportId = 1642

Key Findings:

  1. Top Areas of Interest for RPA Use
  2. Validated Adoption: Where Are Bots Being Used Today?
  3. Databound Excels at Complex Installations/Use Cases; Colburn Hill Group Performs Well in Simpler Settings
  4. Databound & Colburn Hill Group Receive High Marks for Relationships; Olive and UiPath Stumble in Key Metrics
  5. Most Organizations Expect to Increase RPA Use, with Boston, Databound, UiPath Customers Expanding a Variety of Non-RCM Use Cases
 Download Report

This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2021 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.